Orthofix Medical, Inc. (OFIX)
12.71
+0.32
(+2.58%)
USD |
NASDAQ |
Apr 17, 16:00
12.72
+0.02
(+0.12%)
Pre-Market: 20:00
Orthofix Medical SG&A Expense (Quarterly) : 136.75M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Repligen Corp. | 74.36M |
| InfuSystem Holdings, Inc. | 16.51M |
| Tandem Diabetes Care, Inc. | 113.10M |
| Abbott Laboratories | 3.74B |
| Plus Therapeutics, Inc. | 4.168M |